Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
4.330
-0.060 (-1.37%)
At close: May 9, 2025, 4:00 PM
4.330
0.00 (0.00%)
After-hours: May 9, 2025, 7:59 PM EDT

Recursion Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cash & Equivalents
500.45594.35391.57549.91285.12262.13
Upgrade
Short-Term Investments
----231.45-
Upgrade
Cash & Short-Term Investments
500.45594.35391.57549.91516.56262.13
Upgrade
Cash Growth
68.89%51.79%-28.79%6.46%97.07%275.09%
Upgrade
Accounts Receivable
----0.030.16
Upgrade
Other Receivables
46.1249.173.092.759.06-
Upgrade
Receivables
46.1249.173.092.759.090.16
Upgrade
Restricted Cash
3.083.053.231.281.552
Upgrade
Other Current Assets
32.0267.7140.2515.877.512.16
Upgrade
Total Current Assets
584.15714.27438.14569.81534.72266.44
Upgrade
Property, Plant & Equipment
204.78233.21120.17121.4564.7325.97
Upgrade
Goodwill
158.11148.8752.060.80.80.8
Upgrade
Other Intangible Assets
335.79335.8636.441.311.391.69
Upgrade
Long-Term Deferred Tax Assets
21.93----
Upgrade
Other Long-Term Assets
16.0114.456.897.928.723.69
Upgrade
Total Assets
1,3051,449653.7701.29610.35298.59
Upgrade
Accounts Payable
25.0921.613.954.592.821.07
Upgrade
Accrued Expenses
55.1880.2841.7630.2927.6710.49
Upgrade
Current Portion of Long-Term Debt
8.590.110.040.10.091.07
Upgrade
Current Portion of Leases
11.8522.116.125.95--
Upgrade
Current Unearned Revenue
39.6561.7736.4356.731010
Upgrade
Other Current Liabilities
1.631.594.872.626.080.47
Upgrade
Total Current Liabilities
141.98187.4793.17100.2746.6623.1
Upgrade
Long-Term Debt
16.450.681.10.540.6311.41
Upgrade
Long-Term Leases
56.0285.5943.4144.42--
Upgrade
Long-Term Unearned Revenue
129.61118.7751.2470.266.6716.67
Upgrade
Long-Term Deferred Tax Liabilities
22.4416.581.34---
Upgrade
Other Long-Term Liabilities
4.794.73--13.455.38
Upgrade
Total Liabilities
371.29413.82190.26215.4867.4156.56
Upgrade
Common Stock
00000-
Upgrade
Additional Paid-In Capital
2,5532,4741,4311,125943.147.31
Upgrade
Retained Earnings
-1,634-1,431-967.62-639.56-400.08-213.6
Upgrade
Comprehensive Income & Other
14.15-7.64---0.13-
Upgrade
Total Common Equity
933.951,035463.44485.81542.94-206.29
Upgrade
Shareholders' Equity
933.951,035463.44485.81542.94242.02
Upgrade
Total Liabilities & Equity
1,3051,449653.7701.29610.35298.59
Upgrade
Total Debt
92.91108.4950.6751.010.7212.49
Upgrade
Net Cash (Debt)
407.54485.86340.89498.91515.84249.64
Upgrade
Net Cash Growth
66.11%42.52%-31.67%-3.28%106.63%335.00%
Upgrade
Net Cash Per Share
1.291.771.642.844.1211.46
Upgrade
Filing Date Shares Outstanding
406.92401.99234.65191.23170.7722.31
Upgrade
Total Common Shares Outstanding
406.41396.8234.27191.02170.2722.31
Upgrade
Working Capital
442.16526.8344.97469.55488.06243.34
Upgrade
Book Value Per Share
2.302.611.982.543.19-9.24
Upgrade
Tangible Book Value
440.05550.05374.94483.7540.75-208.78
Upgrade
Tangible Book Value Per Share
1.081.391.602.533.18-9.36
Upgrade
Machinery
-128.2982.2267.6953.0820.78
Upgrade
Construction In Progress
-2.713.238.7516.451.36
Upgrade
Leasehold Improvements
-72.7345.9341.8713.9413.79
Upgrade
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q